Trophoblastic Tumor — Trials

Trophoblastic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–30 of 30 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04684368	A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT	recruiting	Phase 2	160	Children's Oncology GroupNETWORK	4	Sep 23, 2026	clinicaltrials
NCT06790706	IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers(IMMUNORARE5)	active not recruiting	Phase 2	27	Hospices Civils de LyonOTHER	1	Jun 25, 2026	clinicaltrials
NCT02834013	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors	active not recruiting	Phase 2	798	National Cancer Institute (NCI)NIH	2	Jun 17, 2026	clinicaltrials

Data updated 4 days agoSource updated Sep 23, 2026source: clinicaltrials